Vigafyde is a brand name of Vigabatrin, a prescription medicine. The FDA NDC Directory lists 1 Vigafyde product in 1 strength and form.

Pyros Pharms holds the FDA application for Vigafyde (NDA217684, approved June 17, 2024).

Is there a generic or store brand of Vigafyde?

Other products of Vigabatrin are listed with the FDA, but none in exactly the same strength and form as a Vigafyde product.

Vigafyde (Vigabatrin): maker, FDA approval and generic versions

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Vigafyde?: Vigafyde is a brand name of Vigabatrin, a prescription medicine. The FDA NDC Directory lists 1 Vigafyde product in 1 strength and form.
Who makes Vigafyde?: Pyros Pharms holds the FDA application for Vigafyde (NDA217684, approved June 17, 2024).
Is there a generic or store brand of Vigafyde?: Other products of Vigabatrin are listed with the FDA, but none in exactly the same strength and form as a Vigafyde product.
Has Vigafyde been recalled?: No recall linked to Vigafyde products (by their NDC code or label) appears in the FDA enforcement reports we use.

What Vigafyde is

Each Vigafyde product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Vigabatrin · prescription medicine

Strength and form	Product names	Same medicine, other names	Label
vigabatrin 100 mg/mL solution (oral)	Vigafyde	None listed	DailyMed

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Vigabatrin →

FDA approval

NDA: New Drug Application: how a new (usually brand-name) medicine is approved.

FDA applications of Vigafyde products (Drugs@FDA)
Application	Holder	First approved	Products
NDA217684	Pyros Pharms	June 17, 2024	1

Companies that list Vigafyde

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Vigafyde products.

Upsher-Smith Laboratories, LLC1 product

Recalls

No recall linked to Vigafyde products (by their NDC code or label) appears in the FDA enforcement reports.

Sources

NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers

Vigafyde